Barclays’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Barclays's ALAB Position: Q3 2026 in Review
Barclays increased its Astera Labs (ALAB) stake by 19% in Q3 2026, buying an estimated $70.2M and bringing the position to 1,349,025 shares worth $480M. The position accounts for 0.1% of the portfolio, ranked #127.
Barclays first reported a position in ALAB in Q1 2024 and has held it in 11 quarters since. The position peaked at $546M in Q2 2026. 493 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.
- Barclays held 1,349,025 shares of Astera Labs worth $480M as of Q3 2026.
- Barclays bought 218,081 Astera Labs shares in Q3 2026, an estimated $70.2M.
- Astera Labs made up 0.1% of Barclays's portfolio in Q3 2026, its #127 holding.
- Barclays first reported a position in Astera Labs in Q1 2024 and has held it in 11 quarters since.
- Barclays's Astera Labs position peaked at $546M in Q2 2026.
- 493 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.